1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
    Share Fallers

    Why CSL, Liontown, Pilbara Minerals, and WiseTech shares are sinking today

    | James Mickleboro

    These shares are being sold off on Tuesday. But why?

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Market News

    Why did CSL shares just crash 17%?

    | James Mickleboro

    This biotech is crashing again. Let’s find out why.

    Read more »

    A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
    Blue Chip Shares

    Buy, hold, sell: ANZ, CSL, and Telstra shares

    | James Mickleboro

    Analysts have given their verdict on these popular blue chip shares.

    Read more »

    A young man stands facing the camera and scratching his head with the other hand held upwards wondering if he should buy Whitehaven Coal shares
    Healthcare Shares

    How on earth have CSL shares fallen by 28%?

    | James Mickleboro

    Investors have been hitting the sell button in a panic in 2025.

    Read more »

    A man wearing a white coat holds his hands up and mouth open with joy.
    Healthcare Shares

    Are CSL shares a buy for passive income?

    | Tristan Harrison

    Can this business provide investors with healthy dividends?

    Read more »

    Excited couple celebrating success while looking at smartphone.
    Broker Notes

    Brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    Person holding Australian dollar notes, symbolising dividends.
    How to invest

    How to build a $250,000 ASX share portfolio from scratch

    | James Mickleboro

    It may not be as hard as you think to build a life-changing investment portfolio.

    Read more »

    A woman shrugs and pulls awkward expression with her face.
    Healthcare Shares

    Is there any value left in CSL shares?

    | Samantha Menzies

    Is there any upside left on CSL shares?

    Read more »

    Doctor checking patient's spine x-ray image.
    Healthcare Shares

    Four healthcare stocks Wilsons Advisory says are worth a look

    | Cameron England

    It's time to run the ruler over Australian healthcare stocks.

    Read more »

    A doctor shrugs and holds his hands out.
    Broker Notes

    Macquarie cuts its price target on CSL shares. Is it still a buy?

    | Laura Stewart

    Macquarie reveals new price target after analysing CSL's demerger plans.

    Read more »

    Male investor holds a microscope to his eye to represent scrutiny of Wesfarmers share price
    Share Market News

    Top 10 most traded Australian shares revealed

    | Samantha Menzies

    These ASX shares were in focus last week.

    Read more »

    Sell buy and hold on a digital screen with a man pointing at the sell square.
    Healthcare Shares

    Down 28% in a year, should you buy CSL shares now?

    | Bernd Struben

    A leading expert delivers his verdict on the outlook for CSL shares.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note